Taking place 22-24 March at the Hangzhou Grand Convention & Exhibition Center, CACLP 2025—the 22nd China International In Vitro Diagnostic Expo—will make a significant impact, bringing a sharp focus to global innovation and industry collaboration. With the theme "Innovation for a Better Future", the event is set to bring together industry leaders and emerging players. The preliminary exhibitor list features an impressive range of global participants, ready to showcase cutting-edge advancements and connect with local resources in China’s fast growing in vitro diagnostics (IVD) market.
On 26 October 2024, China Association of In-Vitro Diagnostics (CAIVD) hosted the IVD Youth Entrepreneur' Working Conference in Hangzhou. Representatives from over 20 IVD companies were invited to participate in this gathering.
On 26 October 2024, China Association of In-Vitro Diagnostics (CAIVD) held its Raw Materials & Parts Working Conference in Hangzhou, attracting close to 20 distinguished representatives from industry, academia, and research.
From 20 September to 3 October, 2024, CACLP held a series of five successful online promotional webinars, aimed at fostering international collaboration within the in vitro diagnostics (IVD) industry.
The 22nd China International In Vitro Diagnostic Expo by CACLP will take place 22-24 March 2025 at Hangzhou Grand Convention & Exhibition Center in Hangzhou, Zhejiang Province, China. A diverse range of concurrent academic activities will commence on 21 March, offering a comprehensive and valuable experience.
✔ All (5)
✔ Press release (5)
✔ Industry news (0)
Don’t miss important updates about the show and the in vitro diagnostic industry.
Sign-up for our newsletter today.
Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.